Kinesin inhibitors as cancer therapeutics

Details for Australian Patent Application No. 2008337570 (hide)

Owner Novartis AG

Inventors Faure, Michel; Abrams, Tinya; Barsanti, Paul; Duhl, David; Renhowe, Paul A.; Walter, Annette Olga

Agent Davies Collison Cave

Pub. Number AU-B-2008337570

PCT Pub. Number WO2009/077448

Priority 61/013,966 14.12.07 US

Filing date 12 December 2008

Wipo publication date 25 June 2009

Acceptance publication date 5 April 2012

International Classifications

C07D 233/00 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

3 June 2010 PCT application entered the National Phase

  PCT publication WO2009/077448 Priority application(s): WO2009/077448

5 April 2012 Application Accepted

  Published as AU-B-2008337570

2 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008337600-Promoters from brassica napus for seed specific gene expression

2008337569-Process for degrading zearalenone in a feed product employing laccase